Vitamin D and the Influenza Epidemic
Phase 3
Completed
- Conditions
- Influenza
- Interventions
- Drug: choleclaciferol
- Registration Number
- NCT01182870
- Lead Sponsor
- University of Tromso
- Brief Summary
Subjects included in ongoing vitamin d intervention trials were asked by questionnaire if they were ill with influenza during the winter season 2009/2010 to see if vitamin d supplementation prevented flu like disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 569
Inclusion Criteria
- participant in vitamin D versus placebo study
Exclusion Criteria
- none
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description cholecalciferol choleclaciferol cholecalciferol in doses 800-6000 IU per day placebo choleclaciferol placebo identical looking as cholecalciferol capsules
- Primary Outcome Measures
Name Time Method influenza during the winter season 2009/2010 up to 30 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Tromsø
🇳🇴Tromsø, Norway